🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
03/08/2011 0,1898 USD
11/05/2011 0,1898 USD
02/02/2011 0,1898 USD
04/11/2010 0,1708 USD
04/08/2010 0,1708 USD
05/05/2010 0,1708 USD
03/02/2010 0,1708 USD
04/11/2009 0,1518 USD
05/08/2009 0,1518 USD
06/05/2009 0,1518 USD
04/02/2009 0,3036 USD
05/11/2008 0,3036 USD
06/08/2008 0,3036 USD
07/05/2008 0,3036 USD
06/02/2008 0,3036 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/12/2001 41,08 41,44 40,89 41,30 +0,21% 1,34% 11.672.734
04/12/2001 41,13 41,33 40,94 41,21 -0,57% 0,95% 10.430.489
03/12/2001 41,24 41,65 41,06 41,45 +0,88% 1,43% 10.231.494
30/11/2001 41,41 41,52 40,99 41,09 -0,39% 1,28% 9.921.197
29/11/2001 40,97 41,41 40,89 41,25 +0,72% 1,27% 9.410.112
28/11/2001 41,28 41,50 40,96 40,96 -0,99% 1,31% 8.452.869
27/11/2001 41,35 41,78 41,04 41,37 -0,68% 1,79% 10.871.588
26/11/2001 41,33 41,75 41,03 41,65 +0,57% 1,72% 11.367.495
23/11/2001 41,41 41,65 41,09 41,41 +0,05% 1,35% 3.806.943
21/11/2001 41,12 41,56 41,08 41,39 +1,04% 1,15% 9.604.048
20/11/2001 41,06 41,30 40,74 40,97 +0,00% 1,36% 12.758.565
19/11/2001 40,80 41,17 40,67 40,97 +1,05% 1,21% 13.613.359
16/11/2001 40,68 40,70 40,23 40,54 +0,19% 1,17% 11.089.345
15/11/2001 40,37 40,75 40,02 40,46 +0,64% 1,81% 10.140.956
14/11/2001 40,39 40,52 40,03 40,21 -0,47% 1,22% 10.636.019
13/11/2001 40,04 40,40 39,78 40,40 +1,24% 1,54% 11.169.976
12/11/2001 39,97 40,25 39,49 39,91 -0,17% 1,90% 7.482.662
09/11/2001 40,13 40,31 39,59 39,97 -0,40% 1,80% 8.527.071
08/11/2001 40,22 40,41 39,86 40,13 +0,38% 1,37% 10.346.486
07/11/2001 39,92 40,46 39,91 39,98 -0,40% 1,38% 11.923.797
06/11/2001 39,75 40,30 39,32 40,14 +0,83% 2,48% 11.948.355
05/11/2001 40,37 40,69 39,66 39,81 -0,57% 2,56% 11.647.543
02/11/2001 40,55 40,61 39,91 40,04 -1,26% 1,71% 10.996.277
01/11/2001 39,85 40,56 39,75 40,55 +2,00% 2,02% 13.237.924
31/10/2001 40,23 40,31 39,63 39,75 -1,30% 1,70% 11.547.940
30/10/2001 40,31 40,60 39,91 40,28 -0,28% 1,72% 10.955.803
29/10/2001 40,34 40,83 40,33 40,39 -0,30% 1,25% 11.147.315
26/10/2001 40,15 40,74 39,98 40,51 -0,72% 1,89% 10.837.860
25/10/2001 39,90 40,88 39,56 40,81 +0,12% 3,31% 13.745.952
24/10/2001 40,40 41,03 40,23 40,76 +0,73% 2,00% 13.285.038